Cg Oncology Inc [CGON] stock prices are up 4.25% to $42.44 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGON shares have gain 3.49% over the last week, with a monthly amount glided 1.10%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on October 08, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $90. Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $55. JP Morgan started tracking the stock assigning an Overweight rating and suggested a price target of $41 on May 02, 2025. Scotiabank initiated its recommendation with a Sector Perform and recommended $23 as its price target on April 16, 2025. In a note dated October 24, 2024, UBS initiated a Buy rating and provided a target price of $60 on this stock.
The stock price of Cg Oncology Inc [CGON] has been fluctuating between $14.80 and $45.56 over the past year. Currently, Wall Street analysts expect the stock to reach $71.25 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $42.44 at the most recent close of the market. An investor can expect a potential return of 67.88% based on the average CGON price forecast.
Analyzing the CGON fundamentals
The Cg Oncology Inc [NASDAQ:CGON] reported sales of 2.17M for trailing twelve months, representing a surge of 3774.42%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -82.85%, Pretax Profit Margin comes in at -49.53%, and Net Profit Margin reading is -49.53%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.15 and Total Capital is -0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.82 points at the first support level, and at 39.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.31, and for the 2nd resistance point, it is at 44.17.
Ratios To Look Out For
It’s worth pointing out that Cg Oncology Inc [NASDAQ:CGON]’s Current Ratio is 22.79. Further, the Quick Ratio stands at 22.74, while the Cash Ratio is 1.48. Considering the valuation of this stock, the price to sales ratio is 1577.64, the price to book ratio is 4.83.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Nov 17 ’25 when 1000.0 shares were sold. Director, POST LEONARD E completed a deal on Oct 13 ’25 to sell 1000.0 shares. Meanwhile, Director Mulay James sold 5903.0 shares on Oct 09 ’25.
